rs598819
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001845.6(COL4A1):c.780+60T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.996 in 1,443,548 control chromosomes in the GnomAD database, including 716,581 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.98 ( 73396 hom., cov: 30)
Exomes 𝑓: 1.0 ( 643185 hom. )
Consequence
COL4A1
NM_001845.6 intron
NM_001845.6 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.854
Publications
6 publications found
Genes affected
COL4A1 (HGNC:2202): (collagen type IV alpha 1 chain) This gene encodes a type IV collagen alpha protein. Type IV collagen proteins are integral components of basement membranes. This gene shares a bidirectional promoter with a paralogous gene on the opposite strand. The protein consists of an amino-terminal 7S domain, a triple-helix forming collagenous domain, and a carboxy-terminal non-collagenous domain. It functions as part of a heterotrimer and interacts with other extracellular matrix components such as perlecans, proteoglycans, and laminins. In addition, proteolytic cleavage of the non-collagenous carboxy-terminal domain results in a biologically active fragment known as arresten, which has anti-angiogenic and tumor suppressor properties. Mutations in this gene cause porencephaly, cerebrovascular disease, and renal and muscular defects. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2014]
COL4A1 Gene-Disease associations (from GenCC):
- brain small vessel disease 1 with or without ocular anomaliesInheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Ambry Genetics, PanelApp Australia, Orphanet, Genomics England PanelApp
- autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndromeInheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, Ambry Genetics
- microangiopathy and leukoencephalopathy, pontine, autosomal dominantInheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
- familial porencephalyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- pontine autosomal dominant microangiopathy with leukoencephalopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- retinal arterial tortuosityInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- muscular dystrophy-dystroglycanopathy, type AInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 13-110207343-A-G is Benign according to our data. Variant chr13-110207343-A-G is described in ClinVar as Benign. ClinVar VariationId is 1235813.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.994 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.981 AC: 149310AN: 152132Hom.: 73356 Cov.: 30 show subpopulations
GnomAD3 genomes
AF:
AC:
149310
AN:
152132
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.998 AC: 1288759AN: 1291298Hom.: 643185 AF XY: 0.998 AC XY: 650422AN XY: 651496 show subpopulations
GnomAD4 exome
AF:
AC:
1288759
AN:
1291298
Hom.:
AF XY:
AC XY:
650422
AN XY:
651496
show subpopulations
African (AFR)
AF:
AC:
28518
AN:
30560
American (AMR)
AF:
AC:
44342
AN:
44474
Ashkenazi Jewish (ASJ)
AF:
AC:
25034
AN:
25034
East Asian (EAS)
AF:
AC:
38808
AN:
38808
South Asian (SAS)
AF:
AC:
82757
AN:
82774
European-Finnish (FIN)
AF:
AC:
53338
AN:
53338
Middle Eastern (MID)
AF:
AC:
5442
AN:
5464
European-Non Finnish (NFE)
AF:
AC:
956013
AN:
956090
Other (OTH)
AF:
AC:
54507
AN:
54756
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
119
237
356
474
593
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
17540
35080
52620
70160
87700
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.981 AC: 149405AN: 152250Hom.: 73396 Cov.: 30 AF XY: 0.982 AC XY: 73122AN XY: 74440 show subpopulations
GnomAD4 genome
AF:
AC:
149405
AN:
152250
Hom.:
Cov.:
30
AF XY:
AC XY:
73122
AN XY:
74440
show subpopulations
African (AFR)
AF:
AC:
38796
AN:
41516
American (AMR)
AF:
AC:
15219
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
AC:
3472
AN:
3472
East Asian (EAS)
AF:
AC:
5156
AN:
5156
South Asian (SAS)
AF:
AC:
4822
AN:
4822
European-Finnish (FIN)
AF:
AC:
10612
AN:
10612
Middle Eastern (MID)
AF:
AC:
294
AN:
294
European-Non Finnish (NFE)
AF:
AC:
68039
AN:
68044
Other (OTH)
AF:
AC:
2083
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.510
Heterozygous variant carriers
0
129
257
386
514
643
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
914
1828
2742
3656
4570
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3460
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jun 26, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.